News | May 25, 2024
Heuron gets FDA green light for stroke triage and notification solution
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
2024 full-year revenue guidance raised by US$ 2 billion
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Sales reflect continued strong growth in oncology and vaccines
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Longest survival follow-up ever reported for immunotherapy treatment in this setting
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
